MiREA-AC App for Alcoholism and Marijuana Addiction
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this STTR Phase I funded study is to address the urgent need for an effective primary prevention approach to the problem of heavy episodic drinking and cannabis misuse among mandated college students. Smartphone app interventions are expanding and can offer accessible, scalable, and cost-effective tools. The study will be used to attune a successful evidence-based mHealth smartphone (SP) application (MiREA-AC) focused on alcohol and Cannabis misuse by college students with enhanced content to promote health-seeking behaviors. To test and disseminate the adapted prototype (MiREA-AC), a multisite pilot trial will be conducted to obtain data on the intervention's usability and feasibility in modifying alcohol and cannabis use.
Are You a Good Fit for This Trial?
This trial is for college students who have consumed alcohol in the past 90 days and may be struggling with heavy episodic drinking or cannabis misuse. The study aims to help them reduce their substance use through a smartphone app.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Alpha Testing
Theater and field testing to examine the accuracy and address potential technical issues of the developed app
Treatment
Participants use the MiREA-AC app for two weeks, receiving personalized feedback and completing baseline questionnaires
Pilot Study
Multi-site pilot feasibility trial to assess feasibility and accessibility of the app
Follow-up
Participants are monitored for usability and acceptability of the app, and report on alcohol and cannabis use and consequences
What Are the Treatments Tested in This Trial?
Interventions
- MiREA-AC
Trial Overview
The MiREA-AC, an mHealth smartphone application designed to prevent heavy drinking and cannabis misuse among mandated college students, is being tested for its effectiveness in promoting healthier behaviors.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
experimental arm receives two week dose of the MiREA intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
mHealth Systems Inc.
Lead Sponsor
University of North Carolina, Charlotte
Collaborator
Boston Children's Hospital
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.